Lipidated macrocyclic peptide S-880008 inhibits SARS-CoV-2 fusion by suppressing protomer dissociation at conserved spike sites
S-880008 is a lipidated macrocyclic peptide that broadly inhibits SARS-CoV-2 variants. By locking spike proteins in a fusion-incompetent state through interactions with conserved sites, it blocks viral entry and protects against infection in vivo.